Warning Letter

Case 716495 — FEI 2244771

Action Details

Facility
Novo Nordisk Inc.
Date
September 9, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Plainsboro, NJ (United States)